Tags

Type your tag names separated by a space and hit enter

Coffee, decaffeinated coffee, tea intake, and risk of renal cell cancer.
Nutr Cancer. 2009; 61(1):76-80.NC

Abstract

The relation between coffee, decaffeinated coffee, and tea intake and renal cell carcinoma (RCC) risk was analyzed in a case-control study conducted in Italy between 1992 and 2004. Cases were 767 subjects with incident histologically confirmed RCC and controls were 1,534 patients in hospital for acute non neoplastic conditions. Odds ratios (OR) and 95% confidence intervals (CI) for RCC were computed by multiple logistic regression models, conditioned on study center, sex, and age. Coffee intake (mostly espresso and mocha) was not associated with RCC risk, with an OR of 1.02 (95% CI 0.73-1.43) in drinkers of > or = 4 cups/day compared with drinkers of < 1 cup/day. The corresponding ORs were 1.34 (95% CI 0.87-2.07) in men and 0.67 (95% CI 0.38-1.18) in women, 1.91 (95% CI 0.85-4.31) in current smokers and 0.74 (95% CI 0.41-1.31) in never smokers, with no trend in risk with dose. No relation was observed with decaffeinated coffee (OR = 1.38, 95% CI 0.94-2.03 for drinkers compared with nondrinkers) and tea intake (OR = 0.78, 95% CI 0.59-1.05 for drinkers of > or = 1 cup/day compared with nondrinkers). No significant heterogeneity was found for coffee intake across strata of age, education, body mass index, and consumption of sugar. This study, based on a large dataset, provides further evidence that coffee, decaffeinated coffee, and tea consumption are not related to RCC risk.

Authors+Show Affiliations

Servizio di Epidemiologia, Istituto Tumori Fondazione Pascale, Naples, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19116877

Citation

Montella, Maurizio, et al. "Coffee, Decaffeinated Coffee, Tea Intake, and Risk of Renal Cell Cancer." Nutrition and Cancer, vol. 61, no. 1, 2009, pp. 76-80.
Montella M, Tramacere I, Tavani A, et al. Coffee, decaffeinated coffee, tea intake, and risk of renal cell cancer. Nutr Cancer. 2009;61(1):76-80.
Montella, M., Tramacere, I., Tavani, A., Gallus, S., Crispo, A., Talamini, R., Dal Maso, L., Ramazzotti, V., Galeone, C., Franceschi, S., & La Vecchia, C. (2009). Coffee, decaffeinated coffee, tea intake, and risk of renal cell cancer. Nutrition and Cancer, 61(1), 76-80. https://doi.org/10.1080/01635580802670754
Montella M, et al. Coffee, Decaffeinated Coffee, Tea Intake, and Risk of Renal Cell Cancer. Nutr Cancer. 2009;61(1):76-80. PubMed PMID: 19116877.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Coffee, decaffeinated coffee, tea intake, and risk of renal cell cancer. AU - Montella,Maurizio, AU - Tramacere,Irene, AU - Tavani,Alessandra, AU - Gallus,Silvano, AU - Crispo,Anna, AU - Talamini,Renato, AU - Dal Maso,Luigino, AU - Ramazzotti,Valerio, AU - Galeone,Carlotta, AU - Franceschi,Silvia, AU - La Vecchia,Carlo, PY - 2009/1/1/entrez PY - 2009/1/1/pubmed PY - 2009/4/29/medline SP - 76 EP - 80 JF - Nutrition and cancer JO - Nutr Cancer VL - 61 IS - 1 N2 - The relation between coffee, decaffeinated coffee, and tea intake and renal cell carcinoma (RCC) risk was analyzed in a case-control study conducted in Italy between 1992 and 2004. Cases were 767 subjects with incident histologically confirmed RCC and controls were 1,534 patients in hospital for acute non neoplastic conditions. Odds ratios (OR) and 95% confidence intervals (CI) for RCC were computed by multiple logistic regression models, conditioned on study center, sex, and age. Coffee intake (mostly espresso and mocha) was not associated with RCC risk, with an OR of 1.02 (95% CI 0.73-1.43) in drinkers of > or = 4 cups/day compared with drinkers of < 1 cup/day. The corresponding ORs were 1.34 (95% CI 0.87-2.07) in men and 0.67 (95% CI 0.38-1.18) in women, 1.91 (95% CI 0.85-4.31) in current smokers and 0.74 (95% CI 0.41-1.31) in never smokers, with no trend in risk with dose. No relation was observed with decaffeinated coffee (OR = 1.38, 95% CI 0.94-2.03 for drinkers compared with nondrinkers) and tea intake (OR = 0.78, 95% CI 0.59-1.05 for drinkers of > or = 1 cup/day compared with nondrinkers). No significant heterogeneity was found for coffee intake across strata of age, education, body mass index, and consumption of sugar. This study, based on a large dataset, provides further evidence that coffee, decaffeinated coffee, and tea consumption are not related to RCC risk. SN - 1532-7914 UR - https://www.unboundmedicine.com/medline/citation/19116877/Coffee_decaffeinated_coffee_tea_intake_and_risk_of_renal_cell_cancer_ L2 - https://www.tandfonline.com/doi/full/10.1080/01635580802670754 DB - PRIME DP - Unbound Medicine ER -